🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› USA
Clinical trial register · United States · industry-sponsored

Industry-sponsored studies with a US investigative site

Every industry-sponsored study on the ClinicalTrials.gov registry that lists a US site and is open, about to open, active-but-closed, or enrolling by invitation. This deliberately excludes academic and other non-industry sponsors — the full US registry across all sponsors runs to over 22,000 recruiting studies alone.

Download CSV
Source: ClinicalTrials.gov. Complete coverage of the industry-sponsored slice — all 9110 matching records are in this view (non-industry sponsors are out of scope by design, not truncated). Synced 22 Sep 2026, 03:16 UTC
9110
Studies in scope
industry-sponsored, all four open statuses
4947
Recruiting now
open to new participants
2198
Lead sponsors
across recruiting studies
Top states
California 5292 Florida 4393 Illinois 2478 Georgia 2343 Arizona 2230
Narrow the register
Recruitment status
Phase
Lead sponsor
AstraZeneca299 Novartis Pharmaceuticals202 Eli Lilly and Company190 Merck Sharp & Dohme LLC183 AbbVie172
State
California5292 Florida4393 Illinois2478 Georgia2343 Arizona2230
All 51 states
Target enrolment
to
9110 of 9110 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
US states
Start
Recruiting
Study of Pembrolizumab + Pemetrexed + Platinum Chemotherapy With or Without Zoldonrasib as First Line Treatment in Metastatic Non-squamous RAS G12D-Mutated NSCLC
NCT07777822NSCLC, Non-small Cell Lung Cancer, Non-Small Cell Lung Cancer NSCLC, Non-Squamous Non Small Cell Lung Cancer
Revolution Medicines, Inc.
Phase 3
430
Florida
2026-08-14
Recruiting
RELIEVE Study: NT 201 Intravesical Administration Using Vibe System (ViXe Combination Product) for the Treatment of Idiopathic Overactive Bladder
NCT07553065Overactive Bladder (OAB)
Vensica Therapeutics Ltd.
Phase 2
210
Nevada
2026-08-14
Recruiting
Caring Recharge Project for Caregivers of Individuals With Alzheimer's Disease
NCT07764185Caregiver Stress
Photozig, Inc.
Phase 2
150
California
2026-08-14
Not yet open
Radicle Energy™ DNB: A Study Assessing the Impact of Health and Wellness Products on Fatigue and Related Health Outcomes
NCT07745010Fatigue
Radicle Science
Not applicable
1,320
California
2026-08-13
Recruiting
Pacritinib Effectiveness in Real-world Settings
NCT07774455Myelofibrosis (MF)
Swedish Orphan Biovitrum
Observational
60
Connecticut, Ohio, South Carolina
2026-08-13
Recruiting
A Study to Evaluate the Efficacy, Safety and Tolerability of ALKS 2680 in Adults With Narcolepsy Type 1 (Brilliance NT1 - 304)
NCT07540897Narcolepsy Type 1
Alkermes, Inc.
Phase 3
150
Florida, Georgia, Michigan, Missouri, North Carolina, Ohio, South Carolina, Texas
2026-08-13
Recruiting
A Prospective Study of Pediatric Participants up to 16 Years of Age With Methylmalonic Acidemia (MMA) Due to Mutations in the MMUT Gene
NCT07432880Methylmalonic Acidemia (MMA)
Genespire Srl
Observational
30
Pennsylvania
2026-08-13
Recruiting
A Study to Assess Safety and Efficacy of SOT109 in Patients With Advanced Unresectable or Metastatic Colorectal Cancer
NCT07693751Colorectal Cancer (Locally Advanced or Metastatic)
SOTIO Biotech a.s.
Phase 1/2
100
Texas, Virginia
2026-08-12
Recruiting
Research Study on How Well Oral Semaglutide Works for Weight Loss in Adults With Excess Body Weight
NCT07770841Overweight, Obesity
Novo Nordisk A/S
Phase 3
450
Alabama, California, Florida, Hawaii, Kentucky, Missouri, Nevada, Oregon
2026-08-12
Recruiting
A Phase III Study to Assess the Effect of FDC Laroprovstat/Rosuvastatin Compared With Laroprovstat, Rosuvastatin and Placebo on LDL-C in LLT-naïve Patients.
NCT07619131Hypercholesterolaemia
AstraZeneca
Phase 3
600
Alabama, Arizona, California, Colorado, Connecticut, Florida, Georgia, Illinois
2026-08-12
Recruiting
A Chronic Pain Master Protocol (CPMP): A Study of LY4065967 in Participants With Chronic Low Back Pain
NCT07641504Chronic Pain, Low Back Pain
Eli Lilly and Company
Phase 2
150
Alabama, Arizona, California, Connecticut, Florida, Georgia, Illinois, Louisiana
2026-08-12
Recruiting
A First-in-human Research Study on How NNC0721-8060 Works in People Living With Overweight or Obesity
NCT07767175Overweight, Obesity
Novo Nordisk A/S
Phase 1
142
Kansas, Texas
2026-08-12
Not yet open
A Study to Assess Potential Drug-Drug Interactions of E2086 in Healthy Participants
NCT07766369Healthy Volunteers
Eisai Inc.
Phase 1
93
Texas
2026-08-12
Recruiting
A Study of V132 in Healthy Older Participants (V132-001)
NCT07712575Healthy
Merck Sharp & Dohme LLC
Phase 1
280
California, Florida, Missouri, Nebraska, Ohio, Texas
2026-08-12
Recruiting
Evaluation of Intra-articular CX-011 to Treat Moderate to Severe Pain From Knee Osteoarthritis
NCT07308834Osteoarthritis of the Knees
CarthroniX, Inc.
Phase 1/2
72
California
2026-08-11
Active, closed
Radicle RestTM VGI: A Study Assessing the Impact of Health and Wellness Products on Sleep and Related Health Outcomes
NCT07744997Sleep Disturbance
Radicle Science
Not applicable
600
California
2026-08-11
Recruiting
Study to Assess KN3835 in the Treatment of Flexible/Semi-Flexible Hammertoe (HMT)
NCT07759362Flexible Hammertoe, Semi-flexible Hammertoe
Endo USA Inc., a Keenova Therapeutics Company
Phase 3
554
California, Florida, Texas, Utah
2026-08-11
Recruiting
Study of Petosemtamab Plus Chemotherapy Versus Cetuximab Plus Chemotherapy in RAS and BRAF Wild-type, Unresectable or Metastatic, Left-sided Colorectal Cancer (LiGeR-CRC1)
NCT07702032Left-sided Colorectal Cancer
Genmab
Phase 3
960
Georgia, Indiana, Missouri, Washington
2026-08-11
Not yet open
A Study on the Immune Response and Safety of an Investigational Combined Measles, Mumps, Rubella and Varicella Vaccine, When Given to Healthy Children 4 to 6 Years of Age
NCT07742644Measles, Mumps, Rubella, Varicella (Chickenpox)
GlaxoSmithKline
Phase 3
1,860
Arkansas, California, Florida, Idaho, Illinois, Kentucky, Louisiana, Missouri
2026-08-11
Recruiting
Phase 3 Study to Assess Efficacy, Safety & Tolerability of OCU410 For Geographic Atrophy Secondary to Dry AMD
NCT07770828Dry Age-related Macular Degeneration
Ocugen
Phase 3
237
Arizona, Pennsylvania, Texas
2026-08-11
Recruiting
A Study of LY3971297 in Participants With Heart Failure
NCT07547540Heart Failure, Heart Failure, Diastolic, Heart Failure, Systolic
Eli Lilly and Company
Phase 1
90
Michigan, Missouri, North Carolina, Texas
2026-08-11
Recruiting
Study of Saroglitazar Magnesium for PBC Patients With Incomplete Response or Intolerant to UDCA Therapy
NCT07424677Primary Biliary Cholangitis
Zydus Therapeutics Inc.
Phase 3
90
Florida
2026-08-11
Recruiting
A Study to Evaluate Sequential Administration of Injections of AGN-151586 Followed by BOTOX in Adult Participants for Treatment of Glabellar Lines
NCT07756580Glabellar Lines
AbbVie
Phase 1
120
Arizona, California, Louisiana, Massachusetts, North Carolina, Tennessee, Texas
2026-08-10
Recruiting
Evaluate the Effectiveness and Safety of BBD-1 Multi-target Immune Enhancement Targeting Agent in the Treatment of Hypersensitivity Reaction (IgA) Vasculitis
NCT07595367Allergic Reaction (IgA) Vasculitis
Qifeng Zhang
Phase 2
30
Maryland
2026-08-10
Recruiting
A Study About the Safety of a Single ASP2020 Eye Injection and if it Helps People With Vision Loss From Stargardt-type Eye Conditions
NCT07734064Stargardt Disease, Stargardt Macular Dystrophy, Stargardt-like Macular Dystrophy
Astellas Institute for Regenerative Medicine
Phase 1
30
Arizona, Ohio, Texas
2026-08-10
Recruiting
Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation
NCT07626411Atrial Fibrillation (AF)
Regeneron Pharmaceuticals
Phase 3
15,364
Alabama, Arizona, California, Florida, Georgia, Indiana, Louisiana, Maryland
2026-08-10
Recruiting
A Study to Assess the Skin Irritation and Sensitization of Estradiol/Levonorgestrel TDS in Healthy Postmenopausal Subjects
NCT07794150Menopause, Healthy Female Participants
Corium Innovations, Inc.
Phase 1
250
Nevada
2026-08-10
Recruiting
Safety, Pharmacokinetics (PK), and Efficacy of ONC-783 in Advanced Solid Tumors
NCT07408258Advanced Solid Tumor
OncoC4, Inc.
Phase 1
20
New York, Pennsylvania, Texas
2026-08-10
Recruiting
MediBeacon® Transdermal GFR System for the Evaluation of Kidney Function in Adults With Heart Failure
NCT07349797Glomerular Filtration Rate, Heart Failure
MediBeacon
Not applicable
15
New York
2026-08-10
Recruiting
A Trial Evaluating Safety, Tolerability and Efficacy of CTX340 in Participants With Hypertension
NCT07758634Hypertension
CRISPR Therapeutics AG
Phase 1/2
69
Florida
2026-08-08
Not yet open
Comparing Facial Aging Between Identical Twins With 3D Imaging
NCT07760532Facial Skin Aging, Facial Volume Loss, Wrinkle Appearance
Ponsky Facial Aesthetics And Plastic Surgery, Llc
Observational
200
Ohio
2026-08-08
Recruiting
Longevity Metrics AI/ML Development Study
NCT07808619Aging, Mortality, Cardiovascular Disease Prevention, Metabolic Syndrome
Longevity Metrics, Inc.
Observational
1,000,000
Colorado
2026-08-08
Not yet open
Safety and Efficacy of a 2,910 nm Fractional Ablative Fiber Laser (UltraClear®) for Improvements of Skin Laxity and Lifting of the Lower Face, Submental, and Neck Treatment Areas
NCT07759817Skin Laxity (Submental and Neck), Skin Lifting and Tightening
FA Corporation
Not applicable
50
Kentucky, Texas
2026-08-07
Recruiting
A Phase 3 Study of Rezpegaldesleukin (NKTR-358) for Patients ≥ 12 Years of Age With Moderate-to-Severe Atopic Dermatitis
NCT07711418Moderate-to-Severe Atopic Dermatitis
Nektar Therapeutics
Phase 3
510
Alabama, California, Florida, Georgia, Louisiana, Missouri, Nevada, New Jersey
2026-08-07
Recruiting
Study of Intrathecal ELP-02 for Charcot-Marie-Tooth Disease Type 4J (CMT4J)
NCT07447557Charcot-Marie-Tooth Disease Type 4J
Elpida Therapeutics SPC
Phase 1/2
8
California, Iowa
2026-08-07
Not yet open
Robotic Minimally Invasive Benign Hysterectomy Post-market Clinical Study With the DEXTER Robotic System
NCT07746531Hysterectomy, Benign Uterine Diseases
Distalmotion SA
Observational
112
Kansas, Texas
2026-08-07
Recruiting
Study of Denikitug (GS-1811) Given Alone or With Nivolumab or Chemotherapy in Adults With Metastatic Gastric, Gastroesophageal Junction (GEJ), and Esophageal Adenocarcinomas
NCT07546812HER2-negative, Gastroesophageal Junction, Esophageal Adenocarcinoma, Gastric Adenocarcinoma
Gilead Sciences
Phase 2
120
Massachusetts, New York
2026-08-07
Recruiting
A Phase 1 Trial of AMG 691 in Healthy Chinese and Japanese Volunteers
NCT07745907Healthy Participants
Amgen
Phase 1
28
Nevada
2026-08-07
Recruiting
A Study to Assess Concentration of TREMFYA in Breast Milk of Lactating Women Who Are Receiving TREMFYA Therapeutically
NCT07654751Psoriasis, Colitis, Ulcerative, Crohn Disease, Arthritis, Psoriatic
Janssen Research & Development, LLC
Phase 4
10
North Carolina
2026-08-07
Recruiting
Study to Assess the Efficacy, Pharmacokinetics, Safety and Tolerability of Atrasentan in Pediatric Patients With Primary IgAN
NCT07498335Berger Disease, Bergers Disease, IgA Nephropathy, Immunoglobulin A Nephropathy
Novartis Pharmaceuticals
Phase 3
28
New Jersey, Ohio, Oklahoma, Tennessee
2026-08-06
Recruiting
A Trial of the Efficacy and Safety of a Fixed Dose of SEP-363856 in Adults With Generalized Anxiety Disorder
NCT07767903Generalized Anxiety Disorder
Otsuka Pharmaceutical Development & Commercialization, Inc.
Phase 3
384
California, Florida, New Jersey, New York, Washington
2026-08-06
By invitation
An Open-Label Study to Assess the Long-Term Safety of Solriamfetol in Children and Adolescents With ADHD
NCT07773883ADHD
Axsome Therapeutics, Inc.
Phase 3
300
Alabama, Florida, Tennessee
2026-08-06
Recruiting
ACX-362E [Ibezapolstat] for Oral Treatment of Recurrent Clostridioides Difficile Infection
NCT07513285Clostridium Difficile Infection Recurrence
Acurx Pharmaceuticals Inc.
Phase 2
20
California, Connecticut, Florida, Georgia, Idaho, Illinois, Massachusetts, Michigan
2026-08-06
Recruiting
Within-Subject Comparison of Adipose Tissue Viability Following Liposuction
NCT07820397Liposuction
Apyx Medical
Not applicable
30
Ohio, Washington
2026-08-06
Recruiting
Study of the Effect of Haemodialysis on the Pharmacokinetics, Safety, and Tolerability of Balcinrenone/Dapagliflozin
NCT07754331Kidney Failure
AstraZeneca
Phase 1
10
Florida
2026-08-06
Recruiting
The Study of Chronic Obstructive Pulmonary Disease (COPD) Participants Treated With Dupilumab (STRIDE) Registry
NCT07612878COPD (Chronic Obstructive Pulmonary Disease)
Sanofi
Observational
350
Indiana, North Carolina, Texas
2026-08-06
Recruiting
Pedal Pump Clinical Trial on Edema V1
NCT07760363Lower Extremity Edema, Congestive Heart Failure(CHF), Chronic Venous Insufficiency (CVI), Kidney Disease
David McVay
Not applicable
60
Oklahoma
2026-08-06
Recruiting
Fainting Detection And Early Warning In Syncope Evaluation Study (ARISE)
NCT07502599Orthostatic Hypotension, Reflex Syncope
Boston Scientific Corporation
Observational
40
Minnesota
2026-08-06
Recruiting
Early Detection of COPD Exacerbations Using Home Monitoring Device
NCT07554352COPD Exacerbation
RespirAI US Inc
Observational
30
Nebraska
2026-08-05
Recruiting
A Study to Assess the Pharmacokinetics, Safety and Tolerability of Single-dose Adagrasib (BMS-986503) in Healthy Participants of Japanese Descent
NCT07723118Healthy Participants
Mirati Therapeutics Inc.
Phase 1
10
California
2026-08-05
Recruiting
Pharmacokinetics, Pharmacodynamics, Safety and Tolerability Evaluation of CTAP101 Extended-release Capsules in Pediatric Participants
NCT07494045CKD Stage 3, CKD Stage 4, Secondary Hyperparathyroidism, VDI
OPKO Health, Inc.
Phase 2
40
Missouri, Ohio, Pennsylvania, South Carolina, Wisconsin
2026-08-05
Recruiting
Reduction or Elimination of Mitral Regurgitation With the SATURN TMVR System (CASSINI-US)
NCT07130994Mitral Regurgitation, Heart Disease
InnovHeart
Not applicable
15
California, New York, Oregon
2026-08-05
Recruiting
A Study of JNJ-98768111 in Participants With Advanced Prostate Cancer
NCT07746713Prostatic Neoplasms
Janssen Research & Development, LLC
Phase 1
100
Florida, Michigan, Utah
2026-08-05
Recruiting
A Study to Evaluate the Efficacy and Safety of Subcutaneous Nomlabofusp in Subjects With Friedreich's Ataxia
NCT07778836Friedreich Ataxia, Friedreich's Ataxia
Larimar Therapeutics, Inc.
Phase 3
150
Illinois, New Jersey, Texas
2026-08-05
Recruiting
A Study of 24 to 52 Weeks Treatment to Evaluate The Efficacy And Safety of Galvokimig in Adult Study Participants With Non-Cystic Fibrosis Bronchiectasis
NCT07720375Non-cystic Fibrosis Bronchiectasis
UCB Biopharma SRL
Phase 2
300
Florida, Pennsylvania, Texas
2026-08-05
Recruiting
A Study to Measure Mirikizumab Levels in Breast Milk of Lactating Participants Receiving Mirikizumab Therapeutically for an Approved Indication
NCT07612267Lactation, Inflammatory Bowel Disease
Eli Lilly and Company
Phase 4
14
Illinois, Iowa, Maryland, New York, Ohio
2026-08-05
Recruiting
A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in Children and Adolescents With Type 2 Diabetes
NCT07282613Diabetes Mellitus, Type 2
Novo Nordisk A/S
Phase 3
80
Connecticut, Florida, Georgia, Illinois, Indiana, Iowa, Michigan, New York
2026-08-04
Recruiting
An Open-Label Pharmacokinetic Study for Patients With Actinic Keratosis on the Upper Extremities or the Face
NCT07729579Actinic Keratosis (AK)
Sun Pharmaceutical Industries Limited
Phase 1
48
Texas
2026-08-04
Recruiting
Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities
NCT07752979Obesity, Overweight
AbbVie
Phase 2
360
Alabama, Arizona, California, Florida, Idaho, Illinois, Kentucky, Missouri
2026-08-04
Recruiting
A Research Study to Compare Two Different Versions of Injectable Cagrilintide and Placebo in People With Excess Body Weight
NCT07745504Overweight, Obesity
Novo Nordisk A/S
Phase 3
285
Georgia, Hawaii, Illinois, Indiana, Kentucky, North Carolina, South Carolina, Virginia
2026-08-04
Recruiting
Study to Assess Linsitinib in Participants With Moderate to Severe Active Thyroid Eye Disease (TED)
NCT07753603Thyroid Eye Disease, TED, Graves Orbitopathy
Sling Therapeutics, Inc.
Phase 3
130
Nevada
2026-08-04
Recruiting
SLR-108 PET Imaging in Subjects With Metastatic Solid Tumors
NCT07728942Metastatic Solid Tumors
Solve Therapeutics
Phase 1
70
California
2026-08-04
Recruiting
A Clinical Trial to Look at the Safety and Immune Responses of the RNA-based Vaccine BNT168 in Adults Living With or Without HIV
NCT07698600HIV -1 Infection
BioNTech SE
Phase 1
126
Texas
2026-08-04
Recruiting
A Study to Assess the Tolerability of Ianalumab (VAY736) With Investigator's Choice Thrombopoietin Receptor Agonist (IC TPO-RA) in Patients With Primary Immune Thrombocytopenia (ITP)
NCT07421167Primary Immune Thrombocytopenia (ITP), Primary Evans Syndrome (ES)
Novartis Pharmaceuticals
Phase 2
164
Arkansas, Connecticut, Florida, Illinois, Louisiana, Minnesota, Montana, New Jersey
2026-08-04
Recruiting
BL-M14D1 Plus Atezolizumab vs Standard of Care in First-Line Extensive-Stage Small Cell Lung Cancer (BrenDeLL-Lung01)
NCT07625644Small Cell Lung Cancer Extensive Stage, Small-cell Lung Cancer, Small Cell Carcinoma, Sclc
SystImmune Inc.
Phase 3
550
Arkansas, California, Florida, New Jersey, Virginia
2026-08-04
Recruiting
A Study of LTX-001 In Adult Participants With Acute Exacerbation of Schizophrenia
NCT07734493Schizophrenia
Leal Therapeutics, Inc
Phase 1
90
Arkansas, California, Florida, Georgia, Maryland, New Jersey, Texas
2026-08-03
Recruiting
A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine
NCT07674654Acute Migraine
Kallyope Inc.
Phase 3
1,000
Alabama, Arizona, Arkansas, California, Colorado, Connecticut, Georgia, Illinois
2026-08-03
Recruiting
QUARTZ: Comparative Effectiveness of Switching From Albuterol to Albuterol/Budesonide Versus Adding Low-dose ICS or LTRA to Albuterol
NCT07787117Asthma
AstraZeneca
Observational
8,000
Delaware
2026-08-03
Not yet open
EPX-HTG for Structural Heart Procedures
NCT07705425Atrial Fibrillation (AF), Mitral Valve (MV) Regurgitation
EchoPixel, Inc.
Not applicable
20
California
2026-08-03
Recruiting
Study of NX-5948 Versus Pirtobrutinib in R/R CLL/SLL
NCT07516093B-cell Lymphoma, Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Nurix Therapeutics, Inc.
Phase 3
620
Georgia, Indiana, Tennessee, Texas, Virginia
2026-08-03
Recruiting
A Study to Learn About the Investigational Drug Rinzimetostat (ORIC-944) in Patients With mCRPC Who Were Previously Treated With Abiraterone Acetate (Himalayas-1)
NCT07723248Metastatic Castration Resistant Prostate Cancer
ORIC Pharmaceuticals
Phase 3
600
Indiana, North Carolina, Ohio, Texas, Utah
2026-08-03
Recruiting
Real-World Study of Foslevodopa/Foscarbidopa to Assess Quality of Life Outcomes in Adult Participants Earlier Within Advanced Parkinson Disease
NCT07227896Parkinson's Disease
AbbVie
Observational
100
Texas
2026-08-03
Recruiting
Study to Assess Safety and Immunogenicity of an Egg-based H5N8 Influenza Vaccine at Multiple Dose Levels Adjuvanted With Matrix-M in Healthy Participants 18 Years of Age and Above.
NCT07779408Healthy Volunteers, Influenza
Sanofi
Phase 1/2
640
Arizona, California, Florida, Georgia, Illinois, Kansas, New York, South Carolina
2026-08-03
Recruiting
A Study to Evaluate the Efficacy and Safety of Tabirafusp Tedromer Compared to Aflibercept in Participants With DME - ALTO
NCT07734844Diabetic Macular Edema (DME)
Kodiak Sciences Inc
Phase 3
910
California, Florida, Maryland, Minnesota, South Carolina
2026-08-03
Recruiting
Determine the Prevalence of Exocrine Pancreatic Insufficiency (EPI) in Pediatric and Adult Participants With Alagille Syndrome After Liver Transplantation
NCT07335523Exocrine Pancreatic Insuficiency
Digestive Care, Inc.
Observational
30
Colorado, New York, Ohio, Oregon, Tennessee, Texas, Washington
2026-08-03
Recruiting
Abuse Potential of Gabapentin Taken Orally Concomitantly With Oxycodone Hydrochloride in Healthy, Non-Drug-Dependent, Recreational Opioid Users
NCT07813026Healthy, Non-Drug- Dependent, Recreational Opioid Users
Viatris Inc.
Phase 4
60
Kansas
2026-08-03
Not yet open
A Phase IIb/III Clinical Study to Evaluate the Efficacy and Safety of APC101 in Patients With Postherpetic Neuralgia.
NCT07599800PHN - Post-Herpetic Neuritis
Andros Pharmaceuticals Co., Ltd.
Phase 2/3
333
Florida
2026-08-01
Recruiting
VETERANS AFFAIRS AUGUSTA
NCT07776600Chronic Pain
Companion IQ, Inc
Not applicable
200
Georgia
2026-08-01
Not yet open
A Clinical Trial To Investigate The Effect Of EA-230 On Hospital Length Of Stay In Patients With Coronary Artery Disease (CAD) Undergoing Coronary Artery Bypass Grafting (CABG) Surgery.
NCT07357675Coronary Artery Disease (CAD), Coronary Artery Bypass Graft Surgery(CABG)
EBI Anti Sepsis BV
Phase 3
300
Minnesota, Pennsylvania
2026-08-01
Recruiting
Study of Resmetirom in Children and Adolescents With MASH
NCT07763015MASH, MASH - Metabolic Dysfunction-Associated Steatohepatitis
Madrigal Pharmaceuticals, Inc.
Phase 2
61
Indiana
2026-08-01
Recruiting
Determine Maximum Tolerated Dose, Safety, and Tolerability of Rhenium (186Re) in Pediatric Recurrent, Refractory or Progressive Ependymoma and High-Grade Glioma
NCT07061626Ependymoma, High Grade Gliomas
Cerenome
Phase 1
56
Illinois
2026-08-01
Not yet open
dMD-002 Pilot Study in Patients With Cavernous Nerve Injury Following Radical Prostatectomy
NCT07564102Prostate Cancer
Mochida Medical USA, Inc.
Phase 1/2
30
New York
2026-08-01
Not yet open
TeleABA for Hospitalized Adolescents and Young Adults With Autism Spectrum Disorder
NCT07701915Autism Spectrum Disorder (ASD)
Caring Technologies, Inc.
Not applicable
120
New Jersey
2026-08-01
Not yet open
A Wearable Sensor Platform for Remote Monitoring of Individuals on the Frontotemporal Dementia Spectrum
NCT07569367Frontotemporal Lobar Degeneration (FTLD), Frontotemporal Dementia (FTD), Corticobasal Degeneration, Corticobasal Syndrome (CBS)
BioSensics
Observational
60
Maryland, Massachusetts
2026-08-01
Not yet open
MRI Evaluation of Graft Maturation Following ACL Reconstruction
NCT07046000ACL Tears
Skye Biologics Holdings, LLC
Observational
10
Texas
2026-08-01
Recruiting
Cryoablation for Monomorphic Ventricular Tachycardia (VTS)
NCT07650032Ventricular Tachycardia, Sustained, Ventricular Tachycardia, Monomorphic
Adagio Medical
Not applicable
100
Arizona, California, Massachusetts, New York, Pennsylvania, South Carolina, Tennessee, Virginia
2026-08-01
Recruiting
HS235 Study in Obese Participants With Pulmonary Hypertension and Heart Failure With Preserved Ejection Fraction (HFpEF)
NCT07123779Pulmonary Hypertension, Heart Failure With Preserved Ejection Fraction
35Pharma Inc
Phase 1/2
126
South Carolina
2026-08
Recruiting
Tempus Open Link for Individual Voices in Innovative Analytics Registry: Platform Protocol for Multimodal Real-World Evidence in Cancer
NCT07756034Cancer, Solid Tumor Cancer, Pediatric Acute Myeloid Leukemia, Hematologic Malignancies
Tempus AI
Observational
1,000
Illinois
2026-08
Not yet open
A Phase 1/2 Study to Evaluate the Safety and Efficacy of Dibotatug (DR-01) in Adults With Bone Marrow Failure Syndromes
NCT07712562Bone Marrow Failure Syndromes, Aplastic Anemias, Severe Aplastic Anemia (SAA), Severe Aplastic Anemia, Relapse
Dren Bio
Phase 1/2
60
California, Florida, Georgia, New York, Ohio, Texas, Virginia, Washington
2026-08
Recruiting
Inobrodib, Pomalidomide and Dexamethasone Versus Standard Available Therapy in Relapsed or Refractory Multiple Myeloma
NCT07772024Multiple Myeloma Refractory, Multiple Myeloma in Relapse
CellCentric Ltd.
Phase 3
450
Florida
2026-08
Recruiting
Study of QUAIL-100 in Pediatric and Young Adult Participants With High-Risk Hematologic Malignancies Who Have Received a Hematopoietic Stem Cell Transplantation
NCT07573111Acute Leukemia, Myelodysplastic Syndrome
Laguna Biotherapeutics, Inc.
Phase 1
12
California
2026-08
Recruiting
A Study of APG-3288 in Relapsed/Refractory Blood Cancers
NCT07424833Relapsed/Refractory Hematological Malignancies, Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Leukemia (CLL/SLL, Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL; Including Richter Transformation), Relapsed/Refractory Mantle Cell Lymphoma (MCL)
Ascentage Pharma Group Inc.
Phase 1
180
California, Florida, Michigan, New Jersey, Texas
2026-08
Not yet open
Evaluation of Male and Female External Catheters for Urine Output Monitoring in the ICU
NCT07744945Urine Output, ICU Patients
C. R. Bard
Observational
32
Utah
2026-08
Not yet open
Trientine Tetrahydrochloride Administered Once a Day for the First Line Treatment of Wilson's Disease Patients.
NCT07465718Wilson's Disease
Orphalan
Phase 3
38
Colorado, Connecticut, Michigan
2026-08
Not yet open
A Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)
NCT07759245Pulmonary Disease, Chronic Obstructive
Eli Lilly and Company
Phase 2
606
Alabama, California, Colorado, Florida, Illinois, Indiana, Massachusetts, Michigan
2026-08
Not yet open
Patient Empowerment Project (PEP) Study
NCT07725458Infertility, Mental Health
Inception Fertility Research Institute, LLC
Observational
100
Florida, Texas
2026-08
Recruiting
Study of NX-5948 in Combination With Other Agents in Adults With B-cell Malignancies
NCT07520006B-cell Lymphoma, Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Nurix Therapeutics, Inc.
Phase 1/2
150
Colorado, Florida, Oregon, Pennsylvania, Tennessee, Texas
2026-08
Recruiting
Real World Evidence of SI-BONE's iFuse TORQ TNT Advancing Treatment of Pelvic Ring Fractures
NCT07530497Fracture; Pelvic, Insufficiency Fractures, Fragility Fracture, Sacroiliac; Fusion
SI-BONE, Inc.
Observational
120
Minnesota, Pennsylvania
2026-08
Recruiting
A Phase 1/2 Study of KK2430 in Participants With Hematologic Neoplasms
NCT07629726Hematologic Neoplasms
Kyowa Kirin Co., Ltd.
Phase 1/2
72
South Carolina
2026-08
Recruiting
Transcatheter Tricuspid Valve Replacement With the Medtronic Intrepid™ Transcatheter Tricuspid Valve Replacement (TTVR) System in Severe Tricuspid Regurgitation
NCT07321899Severe Tricuspid Regurgitation
Medtronic Cardiovascular
Not applicable
1,186
Arizona, California, Minnesota, Ohio
2026-08
Rows per page Showing 401–500 of 9110
Previous 3 4 5 6 7 Next
Cite this view

Priya Life Science (2026). Clinical trial register: industry-sponsored studies with a US investigative site. Derived from ClinicalTrials.gov. Retrieved 22 September 2026. https://priyalifescience.com/clinical-trials-usa?page=5

Query this register directly
GET /api/trials?country=usa&status=recruiting&format=json Try it now →
Listing here is informational and not medical advice; eligibility is determined by each study team. Compare pay for the teams running these studies in the US Pharma Salary Guide, see who's behind them in the US Company Directory, or track approvals on the FDA Approvals Tracker. For Irish, UK and EU sites, see the Ireland, UK and EU registers.